Jingwei Shang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jingwei Shang has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Nozomi Hishikawa
Departments of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Dentistry and Pharmacy, 2-5-1 Shikata-cho, Okayama Okayama Japan
11 shared publications- Toru Yamashita
Department of Neurology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan
10 shared publications Yasuyuki Ohta
Departments of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Dentistry and Pharmacy, 2-5-1 Shikata-cho, Okayama Okayama Japan
9 shared publicationsYumiko Nakano
Department of Neurology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Kita-ku, Okayama Japan
9 shared publicationsMami Takemoto
Departments of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Dentistry and Pharmacy, 2-5-1 Shikata-cho, Okayama Okayama Japan
8 shared publicationsXia Liu
Department of Neurology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Kita-ku, Okayama Japan
8 shared publications
Latest Publications
- 9 December 2025
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 46 (5) , 1219-1237
Neural stem cell transplantation attenuates cognitive decline and neuroinflammation in a mouse model of Alzheimer’s disease with chronic cerebral hypoperfusion
Alzheimer’s disease (AD) and chronic cerebral hypoperfusion (CCH) frequently coexist in aging populations, synergistically aggravating neurodegeneration. To assess the therapeutic potential of stem cell interventions, an AD + CCH mouse model was generated by combining APP/PS1 mice with bilateral common carotid artery stenosis. Neural stem cells (NSCs) or induced pluripotent stem cells (iPSCs) were transplanted into the lateral ventricles at 5 months of age. Behavioral testing, Nissl staining, Western blotting, and immunofluorescence were conducted at 9 and 12 months to evaluate cognition, neuronal survival, cell death pathways (LC3-II, cleaved caspase-3, NLRP3), glial polarization, and neurotrophic/synaptic markers (BDNF, VEGF, VAChT, PSD95). CCH exacerbated AD-related cognitive deficits, neuronal loss, and activation of autophagic, apoptotic, and pyroptotic pathways, accompanied by enhanced M1 microglial polarization, astrogliosis, and downregulation of BDNF and VAChT. NSCs transplantation significantly improved cognitive performance, preserved neuronal integrity, attenuated glial activation, and restored neurotrophic and synaptic protein expression, characterized by increased BDNF, VEGF, and PSD95 levels and partial recovery of VAChT. In contrast, iPSCs transplantation failed to exert comparable effects. These findings demonstrate that NSCs, but not iPSCs, mitigate AD + CCH-induced neuropathology by re-establishing the balance between inflammatory, neurotrophic, and synaptic signaling, supporting NSCs as a promising therapeutic approach for AD with vascular comorbidity.
- 9 December 2025
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 46 (5) , 1219-1237
Neural stem cell transplantation attenuates cognitive decline and neuroinflammation in a mouse model of Alzheimer’s disease with chronic cerebral hypoperfusion
Alzheimer’s disease (AD) and chronic cerebral hypoperfusion (CCH) frequently coexist in aging populations, synergistically aggravating neurodegeneration. To assess the therapeutic potential of stem cell interventions, an AD + CCH mouse model was generated by combining APP/PS1 mice with bilateral common carotid artery stenosis. Neural stem cells (NSCs) or induced pluripotent stem cells (iPSCs) were transplanted into the lateral ventricles at 5 months of age. Behavioral testing, Nissl staining, Western blotting, and immunofluorescence were conducted at 9 and 12 months to evaluate cognition, neuronal survival, cell death pathways (LC3-II, cleaved caspase-3, NLRP3), glial polarization, and neurotrophic/synaptic markers (BDNF, VEGF, VAChT, PSD95). CCH exacerbated AD-related cognitive deficits, neuronal loss, and activation of autophagic, apoptotic, and pyroptotic pathways, accompanied by enhanced M1 microglial polarization, astrogliosis, and downregulation of BDNF and VAChT. NSCs transplantation significantly improved cognitive performance, preserved neuronal integrity, attenuated glial activation, and restored neurotrophic and synaptic protein expression, characterized by increased BDNF, VEGF, and PSD95 levels and partial recovery of VAChT. In contrast, iPSCs transplantation failed to exert comparable effects. These findings demonstrate that NSCs, but not iPSCs, mitigate AD + CCH-induced neuropathology by re-establishing the balance between inflammatory, neurotrophic, and synaptic signaling, supporting NSCs as a promising therapeutic approach for AD with vascular comorbidity.
- 1 August 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 29 (8) , 104818
Antioxidative effects of a novel dietary supplement Neumentix in a mouse stroke model
- 1 August 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 29 (8) , 104818
Antioxidative effects of a novel dietary supplement Neumentix in a mouse stroke model
- 1 May 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 29 (5) , 104743
Bone Marrow Stromal Cell Transplantation Drives Molecular Switch from Autophagy to the Ubiquitin-Proteasome System in Ischemic Stroke Mice
- 1 May 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 29 (5) , 104743
Bone Marrow Stromal Cell Transplantation Drives Molecular Switch from Autophagy to the Ubiquitin-Proteasome System in Ischemic Stroke Mice
- 1 November 2019
- Published by Elsevier in Brain Research
- Vol. 1723, 146379
Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer’s disease model mouse
- 1 November 2019
- Published by Elsevier in Brain Research
- Vol. 1723, 146379
Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer’s disease model mouse
- 1 June 2019
- Published by Elsevier in Neuroscience Research
- Vol. 143, 61-70
Acceleration of NLRP3 inflammasome by chronic cerebral hypoperfusion in Alzheimer’s disease model mouse
- 1 June 2019
- Published by Elsevier in Neuroscience Research
- Vol. 143, 61-70
Acceleration of NLRP3 inflammasome by chronic cerebral hypoperfusion in Alzheimer’s disease model mouse
- Open Access
- 19 December 2018
- Published by Wiley in Journal of Neuroscience Research
- Vol. 97 (5) , 607-619
Enhanced oxidative stress and the treatment by edaravone in mice model of amyotrophic lateral sclerosis
Oxidative stress is associated with the degeneration of both motor neurons and skeletal muscles in amyotrophic lateral sclerosis (ALS). A free radical scavenger edaravone has been proven as a therapeutic drug for ALS patients, but the neuroprotective mechanism for the oxidative stress of ALS has not been fully investigated. In this study, we investigated oxidative stress in ALS model mice bearing both oxidative stress sensor nuclear erythroid 2‐related factor 2 (Nrf2) and G93A‐human Cu/Zn superoxide dismutase (Nrf2/G93A) treated by edaravone. In vivo Nrf2 imaging analysis showed the accelerated oxidative stress both in spinal motor neurons and lower limb muscles of Nrf2/G93A mice according to disease progression in addition to the enhancement of serum oxidative stress marker dROMS. These were significantly alleviated by edaravone treatment accompanied by clinical improvements (rotarod test). The present study suggests that in vivo optical imaging of Nrf2 is useful for detecting oxidative stress in ALS, and edaravone alleviates the degeneration of both motor neurons and muscles related to oxidative stress in ALS patients.
- 19 December 2018
- Published by Wiley in Journal of Neuroscience Research
- Vol. 97 (5) , 607-619
Open AccessEnhanced oxidative stress and the treatment by edaravone in mice model of amyotrophic lateral sclerosis
Oxidative stress is associated with the degeneration of both motor neurons and skeletal muscles in amyotrophic lateral sclerosis (ALS). A free radical scavenger edaravone has been proven as a therapeutic drug for ALS patients, but the neuroprotective mechanism for the oxidative stress of ALS has not been fully investigated. In this study, we investigated oxidative stress in ALS model mice bearing both oxidative stress sensor nuclear erythroid 2‐related factor 2 (Nrf2) and G93A‐human Cu/Zn superoxide dismutase (Nrf2/G93A) treated by edaravone. In vivo Nrf2 imaging analysis showed the accelerated oxidative stress both in spinal motor neurons and lower limb muscles of Nrf2/G93A mice according to disease progression in addition to the enhancement of serum oxidative stress marker dROMS. These were significantly alleviated by edaravone treatment accompanied by clinical improvements (rotarod test). The present study suggests that in vivo optical imaging of Nrf2 is useful for detecting oxidative stress in ALS, and edaravone alleviates the degeneration of both motor neurons and muscles related to oxidative stress in ALS patients.
- 1 December 2018
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 27 (12) , 3521-3528
Reduction of Ischemia Reperfusion-Related Brain Hemorrhage by Stachybotrys Microspora Triprenyl Phenol-7 in Mice With Antioxidant Effects
- 1 December 2018
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 27 (12) , 3521-3528
Reduction of Ischemia Reperfusion-Related Brain Hemorrhage by Stachybotrys Microspora Triprenyl Phenol-7 in Mice With Antioxidant Effects
- 13 August 2018
- Published by Wiley in Journal of Neuroscience Research
- Vol. 96 (10) , 1707-1716
Protective effect of a novel sigma‐1 receptor agonist is associated with reduced endoplasmic reticulum stress in stroke male mice
Sigma‐1 receptor (Sig‐1R) is expressed at endoplasmic reticulum (ER) membranes, where it regulates a variety of specific physiological functions. However, the profile and exact roles of ER stress‐related molecules after Sig‐1R agonist treatment in an in vivo stroke model are largely unknown. The aim of this study is to investigate the effect of a novel Sig‐1R agonist, aniline derivative compound (Comp‐AD), on the ER stress response following ischemic stroke. Male C57BL/6J mice received transient middle cerebral artery occlusion for 90 min, and were then treated with vehicle saline or Comp‐AD at reperfusion. At 3 hr, 1 day, and 7 days after reperfusion, immunohis‐ tochemistry was performed for Sig‐1R and ER stress‐related proteins including phospho protein kinase RNA‐like endoplasmic reticulum kinase (p‐PERK), phospho inositol requiring enzyme 1α (p‐ IRE1α), and activating transcription factor 6 (ATF6). Neurobehavioral analysis showed improved functional recovery at 1 day and 7 days after reperfusion, and the infarct volume was significantly smaller at 7 days (p < .05), in the Comp‐AD group compared with the vehicle group. Comp‐AD treatment upregulated Sig‐1R immunoreactivity at 3 hr and 1 day (p < .05), and reduced p‐PERK and p‐IRE1α expression at 1 day (p < .05, respectively), in the peri‐ischemic region compared with the vehicle group. Treatment with the novel Sig‐1R agonist Comp‐AD was neuroprotective after transient middle cerebral artery occlusion, and was associated with upregulation of Sig‐1R and a reduction of ER stress.
- 13 August 2018
- Published by Wiley in Journal of Neuroscience Research
- Vol. 96 (10) , 1707-1716
Protective effect of a novel sigma‐1 receptor agonist is associated with reduced endoplasmic reticulum stress in stroke male mice
Sigma‐1 receptor (Sig‐1R) is expressed at endoplasmic reticulum (ER) membranes, where it regulates a variety of specific physiological functions. However, the profile and exact roles of ER stress‐related molecules after Sig‐1R agonist treatment in an in vivo stroke model are largely unknown. The aim of this study is to investigate the effect of a novel Sig‐1R agonist, aniline derivative compound (Comp‐AD), on the ER stress response following ischemic stroke. Male C57BL/6J mice received transient middle cerebral artery occlusion for 90 min, and were then treated with vehicle saline or Comp‐AD at reperfusion. At 3 hr, 1 day, and 7 days after reperfusion, immunohis‐ tochemistry was performed for Sig‐1R and ER stress‐related proteins including phospho protein kinase RNA‐like endoplasmic reticulum kinase (p‐PERK), phospho inositol requiring enzyme 1α (p‐ IRE1α), and activating transcription factor 6 (ATF6). Neurobehavioral analysis showed improved functional recovery at 1 day and 7 days after reperfusion, and the infarct volume was significantly smaller at 7 days (p < .05), in the Comp‐AD group compared with the vehicle group. Comp‐AD treatment upregulated Sig‐1R immunoreactivity at 3 hr and 1 day (p < .05), and reduced p‐PERK and p‐IRE1α expression at 1 day (p < .05, respectively), in the peri‐ischemic region compared with the vehicle group. Treatment with the novel Sig‐1R agonist Comp‐AD was neuroprotective after transient middle cerebral artery occlusion, and was associated with upregulation of Sig‐1R and a reduction of ER stress.
- 1 August 2018
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 27 (8) , 2166-2174
Neuroprotective Effects of Tocovid Pretreatment in a Mouse Stroke Model
- 1 August 2018
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 27 (8) , 2166-2174
Neuroprotective Effects of Tocovid Pretreatment in a Mouse Stroke Model
- 1 August 2018
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 27 (8) , 2096-2105
Therapeutic Effects of Pretreatment with Tocovid on Oxidative Stress in Postischemic Mice Brain
- 1 August 2018
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 27 (8) , 2096-2105
Therapeutic Effects of Pretreatment with Tocovid on Oxidative Stress in Postischemic Mice Brain